ERA Congress in Stockholm, Sweden, with a theme of"Rethinking kidney health, transforming kidney care," and a program full of sessions delving into the controversies, challenges and latest research developments in nephrology.
The session marks the first in the history of the ERA congress to focus entirely on the results and implications of a single trial. Other late-breakers also delivering new insights on GLP-1s will include a secondary analysis of the pivotal SELECT trial describing semaglutide in the context of kidney function in people with obesity and cardiovascular disease.
"The congress will highlight the importance of kidney disease as a global public health emergency; the importance of prevention, early detection, and early intervention," Ong said. In a newly introduced PRO-CON debate format, experts will argue both sides on the topics of:"Treatment of obesity in diabetic kidney disease: New drugs are the answer," and"Should we still collect 24h urine to follow-up kidney stone formers?"
Source: Healthcare Press (healthcarepress.net)
Chronic Kidney Failure CKD - Chronic Kidney Disease Chronic Kidney Disease CKD Renal Failure Renal Insufficiency Kidney Insufficiency Kidney Failure Renal Impairment Renal Disease Kidney Disease Kidney Disorder Renal Disorder Nephropathy Kidneys End Stage Renal Disease ESRD - End Stage Renal Disease ESRD ESKD End-Stage Kidney Disease (ESKD)
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: hackernoon - 🏆 532. / 51 Read more »
Source: wwd - 🏆 24. / 68 Read more »
Source: Crypto_Potato - 🏆 568. / 51 Read more »
Source: KPIXtv - 🏆 443. / 53 Read more »
Source: mercnews - 🏆 88. / 68 Read more »
Source: FOX10Phoenix - 🏆 83. / 68 Read more »